Why golimumab in the treatment of psoriatic arthritis, ankylosing spondylitis and rheumatoid arthritis?

Why golimumab in the treatment of psoriatic arthritis, ankylosing spondylitis and rheumatoid arthritis?

Golimumab is an anti-TNF monoclonal antibody administred subcutaneously once a month and produced with an innovative technology that minimizes immunogenicity. This paper reviews and updates the main studies on the efficacy, safety and pharmacoeconomic aspects of treatment with golimumab of psoriatic...

Full description

Bibliographic Details
Main Authors: M. Rossini, O Viapiana, G. Orsolini, E. Fracassi, L. Idolazzi, D. Gatti, S. Adami, M. Govoni
Format: Article
Language:English
Published: PAGEPress Publications 2015-03-01
Series:Reumatismo
Subjects:
Golimumab, Biologics anti-TNF, Psoriatic arthritis, Ankylosing spondylitis, Rheumatoid arthritis.
Online Access:http://www.reumatismo.org/index.php/reuma/article/view/799
id doaj-8d70cd031672426885f9e3dce692b8ee
record_format Article
spelling doaj-8d70cd031672426885f9e3dce692b8ee2020-11-24T22:11:52ZengPAGEPress PublicationsReumatismo0048-74492240-26832015-03-0166428530310.4081/reumatismo.2014.799670Why golimumab in the treatment of psoriatic arthritis, ankylosing spondylitis and rheumatoid arthritis?M. Rossini0O Viapiana1G. Orsolini2E. Fracassi3L. Idolazzi4D. Gatti5S. Adami6M. Govoni7Rheumatology Unit, University of VeronaRheumatology Unit, University of VeronaRheumatology Unit, University of VeronaRheumatology Unit, University of VeronaRheumatology Unit, University of VeronaRheumatology Unit, University of VeronaRheumatology Unit, University of VeronaRheumatology Unit, University of FerraraGolimumab is an anti-TNF monoclonal antibody administred subcutaneously once a month and produced with an innovative technology that minimizes immunogenicity. This paper reviews and updates the main studies on the efficacy, safety and pharmacoeconomic aspects of treatment with golimumab of psoriatic arthritis, ankylosing spondylitis and rheumatoid arthritis.http://www.reumatismo.org/index.php/reuma/article/view/799Golimumab, Biologics anti-TNF, Psoriatic arthritis, Ankylosing spondylitis, Rheumatoid arthritis.
collection DOAJ
language English
format Article
sources DOAJ
author M. Rossini
O Viapiana
G. Orsolini
E. Fracassi
L. Idolazzi
D. Gatti
S. Adami
M. Govoni
spellingShingle M. Rossini
O Viapiana
G. Orsolini
E. Fracassi
L. Idolazzi
D. Gatti
S. Adami
M. Govoni
Why golimumab in the treatment of psoriatic arthritis, ankylosing spondylitis and rheumatoid arthritis?
Reumatismo
Golimumab, Biologics anti-TNF, Psoriatic arthritis, Ankylosing spondylitis, Rheumatoid arthritis.
author_facet M. Rossini
O Viapiana
G. Orsolini
E. Fracassi
L. Idolazzi
D. Gatti
S. Adami
M. Govoni
author_sort M. Rossini
title Why golimumab in the treatment of psoriatic arthritis, ankylosing spondylitis and rheumatoid arthritis?
title_short Why golimumab in the treatment of psoriatic arthritis, ankylosing spondylitis and rheumatoid arthritis?
title_full Why golimumab in the treatment of psoriatic arthritis, ankylosing spondylitis and rheumatoid arthritis?
title_fullStr Why golimumab in the treatment of psoriatic arthritis, ankylosing spondylitis and rheumatoid arthritis?
title_full_unstemmed Why golimumab in the treatment of psoriatic arthritis, ankylosing spondylitis and rheumatoid arthritis?
title_sort why golimumab in the treatment of psoriatic arthritis, ankylosing spondylitis and rheumatoid arthritis?
publisher PAGEPress Publications
series Reumatismo
issn 0048-7449
2240-2683
publishDate 2015-03-01
description Golimumab is an anti-TNF monoclonal antibody administred subcutaneously once a month and produced with an innovative technology that minimizes immunogenicity. This paper reviews and updates the main studies on the efficacy, safety and pharmacoeconomic aspects of treatment with golimumab of psoriatic arthritis, ankylosing spondylitis and rheumatoid arthritis.
topic Golimumab, Biologics anti-TNF, Psoriatic arthritis, Ankylosing spondylitis, Rheumatoid arthritis.
url http://www.reumatismo.org/index.php/reuma/article/view/799
work_keys_str_mv AT mrossini whygolimumabinthetreatmentofpsoriaticarthritisankylosingspondylitisandrheumatoidarthritis
AT oviapiana whygolimumabinthetreatmentofpsoriaticarthritisankylosingspondylitisandrheumatoidarthritis
AT gorsolini whygolimumabinthetreatmentofpsoriaticarthritisankylosingspondylitisandrheumatoidarthritis
AT efracassi whygolimumabinthetreatmentofpsoriaticarthritisankylosingspondylitisandrheumatoidarthritis
AT lidolazzi whygolimumabinthetreatmentofpsoriaticarthritisankylosingspondylitisandrheumatoidarthritis
AT dgatti whygolimumabinthetreatmentofpsoriaticarthritisankylosingspondylitisandrheumatoidarthritis
AT sadami whygolimumabinthetreatmentofpsoriaticarthritisankylosingspondylitisandrheumatoidarthritis
AT mgovoni whygolimumabinthetreatmentofpsoriaticarthritisankylosingspondylitisandrheumatoidarthritis
_version_ 1725803916225937408

Similar Items